Associated Papers
Prenatal-onset of congenital neuronal ceroid lipofuscinosis with a novel CTSD mutation.
Chartier S et al.
Birth Defects Research, 2021
Cathepsin D Variants Associated With Neurodegenerative Diseases Show Dysregulated Functionality and Modified α-Synuclein Degradation Properties.
Bunk J et al.
Frontiers in Cell and Developmental Biology, 2021
Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy.
De Pasquale V et al.
Cells, 2020
The Role of Cathepsin D in the Pathogenesis of Human Neurodegenerative Disorders.
Vidoni C et al.
Medicinal Research Reviews, 2016
Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo.
Cullen V et al.
Molecular Brain, 2009
Novel mutation and the first prenatal screening of cathepsin D deficiency (CLN10).
Fritchie K et al.
Acta Neuropathologica, 2009
Diagnosis of neuronal ceroid lipofuscinosis: mutation detection strategies.
Getty AL et al.
Expert Opinion on Medical Diagnostics, 2007
Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis.
Siintola E et al.
Brain : a Journal of Neurology, 2006
Cathepsin D deficiency and NCL/Batten disease: there's more to death than apoptosis.
Shacka JJ et al.
Autophagy, 0
Select a paper to view details